These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 18175221)

  • 1. Mineral metabolism and bone abnormalities in children with chronic renal failure.
    Sanchez CP
    Rev Endocr Metab Disord; 2008 Jun; 9(2):131-7. PubMed ID: 18175221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone health in chronic kidney disease-mineral and bone disease.
    Gal-Moscovici A; Sprague SM
    Adv Chronic Kidney Dis; 2007 Jan; 14(1):27-36. PubMed ID: 17200041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic kidney disease-mineral-bone disorder: a new paradigm.
    Moe SM; Drüeke T; Lameire N; Eknoyan G
    Adv Chronic Kidney Dis; 2007 Jan; 14(1):3-12. PubMed ID: 17200038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic kidney disease/bone and mineral metabolism: the imperfect storm.
    Williams ME
    Semin Nephrol; 2009 Mar; 29(2):97-104. PubMed ID: 19371800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy.
    Jehle PM; Ostertag A; Schulten K; Schulz W; Jehle DR; Stracke S; Fiedler R; Deuber HJ; Keller F; Boehm BO; Baylink DJ; Mohan S
    Kidney Int; 2000 Feb; 57(2):423-36. PubMed ID: 10652019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Derangements in phosphate metabolism in chronic kidney diseases/endstage renal disease: therapeutic considerations.
    Molony DA; Stephens BW
    Adv Chronic Kidney Dis; 2011 Mar; 18(2):120-31. PubMed ID: 21406297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of unfractionated heparin on renal osteodystrophy and vascular calcification in chronic kidney disease rats.
    Meng Y; Zhang H; Li Y; Li Q; Zuo L
    Bone; 2014 Jan; 58():168-76. PubMed ID: 24145307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bisphosphonate use in chronic kidney disease: association with adynamic bone disease in a bone histology series.
    Amerling R; Harbord NB; Pullman J; Feinfeld DA
    Blood Purif; 2010; 29(3):293-9. PubMed ID: 20090316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Disorders of bone and mineral metabolism in CKD: CKD-MBD as a new entity].
    Tsukamoto Y
    Clin Calcium; 2007 May; 17(5):660-4. PubMed ID: 17470993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal management of bone mineral disorders in chronic kidney disease and end stage renal disease.
    Lundquist AL; Nigwekar SU
    Curr Opin Nephrol Hypertens; 2016 Mar; 25(2):120-6. PubMed ID: 26785065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving global outcomes in mineral and bone disorders.
    Moe SM; Drüeke T
    Clin J Am Soc Nephrol; 2008 Nov; 3 Suppl 3(Suppl 3):S127-30. PubMed ID: 18988697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel therapeutic agents and strategies for the management of chronic kidney disease mineral and bone disorder.
    Connor A
    Postgrad Med J; 2009 May; 85(1003):274-9. PubMed ID: 19520880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D retains an important role in the pathogenesis and management of secondary hyperparathyroidism in chronic renal failure.
    Cozzolino M; Gallieni M; Brancaccio D; Arcidiacono T; Bianchi G; Vezzoli G
    J Nephrol; 2006; 19(5):566-77. PubMed ID: 17136683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Markers of calcium--phosphate metabolism and bones alterations in long term kidney transplant patients].
    Spiechowicz U; Kokot F; Wiecek A
    Przegl Lek; 2003; 60(11):690-4. PubMed ID: 15058034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Vitamin D metabolism and chronic kidney disease].
    Honda H; Sanada D; Akizawa T
    Clin Calcium; 2006 Jul; 16(7):1143-46. PubMed ID: 16816474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Direct effects of vitamin D on bone].
    Kazama JJ
    Clin Calcium; 2004 Sep; 14(9):27-30. PubMed ID: 15577106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of 1,25-dihydroxyvitamin-D3 on renal function, mineral balance, and growth in children with severe chronic renal failure.
    Chan JC; Kodroff MB; Landwehr DM
    Pediatrics; 1981 Oct; 68(4):559-71. PubMed ID: 6895662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The wide spectrum of renal osteodystrophy in children.
    Wolfson BJ; Capitanio MA
    Crit Rev Diagn Imaging; 1987; 27(4):297-319. PubMed ID: 3322679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Function and effect of bone morphogenetic protein-7 in kidney bone and the bone-vascular links in chronic kidney disease.
    Mathew S; Davies M; Lund R; Saab G; Hruska KA
    Eur J Clin Invest; 2006 Aug; 36 Suppl 2():43-50. PubMed ID: 16884397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.